Back
Roivant Sciences Ltd. 10K Form
Sell
48
ROIV
Roivant Sciences Ltd.
Last Price:
$21.18
Seasonality Move:
20.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ROIV News And Ratings
See the #1 stock for the next 7 days that we like better than ROIV
ROIV Financial Statistics
Sales & Book Value
| Annual Sales: | $29.1M |
|---|---|
| Cash Flow: | $-193.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.33 |
| Price / Book: | 3.38 |
Profitability
| EPS (TTM): | -0.55250 |
|---|---|
| Net Income (TTM): | $-901.3M |
| Gross Margin: | $20.8M |
| Return on Equity: | -17.38% |
| Return on Assets: | -16.37% |
Roivant Sciences Ltd. Earnings Forecast
Key Roivant Sciences Ltd. Financial Ratios
-
The Gross Profit Margin over the past 7 years for ROIV is 71.63%.
-
The Selling, General & Administrative Expenses for ROIV have been equal to 2,035.62% of Gross Profit Margin.
-
The Research & Development expenses have been 1,894.51% of Revenue.
-
The Net Earning history of ROIV is -2,511.84% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 3 years.
Roivant Sciences Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ROIV |
| Website: | roivant.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 33.71 |
| Quick Ratio: | 32.78 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.16 |
|---|---|
| Forward P/E Ratio: | 0 |
ROIV Technical Analysis vs Fundamental Analysis
Sell
48
Roivant Sciences Ltd. (ROIV)
is a Sell
Is Roivant Sciences Ltd. a Buy or a Sell?
-
Roivant Sciences Ltd. stock is rated a SellThe current Roivant Sciences Ltd. [ROIV] share price is $21.18. The Score for ROIV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.